Unleashing the Power of Clinical Trial Data

Data leaders and transparency leaders in the pharma industry are increasingly embracing a digital shift in which clinical trial data is reused for new benefits, including future trial design.  As the industry tackles the cost of R&D and strives for innovation, bringing new life to clinical trial data is increasingly relevant.  As data are reused for new benefits beyond a single trial, cultural, policy, and privacy challenges must be addressed alongside technological advancements in making data findable, accessible, interoperable, and reusable (FAIR).

This webinar explores how the industry is shifting and what it could mean for your data strategy. Special emphasis was placed on how Novartis is transforming medicine with 2 million patient years of data.

Learning Objectives

At the conclusion of this webinar, participants should be able to understand:

• How clinical data can be safely reused for new benefits, including to accelerate drug R&D
• How to break down data silos organizationally, culturally, and technically
• How to build innovation networks and safely share data amongst innovation partners – further accelerating and enhancing the impact of digital innovations

Featured Topics

• The complexity of reapplying data collected in clinical trials, and the opportunities to drive new insights by enhancing their accessibility
• How privacy and data anonymization with speed, scale, and precision underpin safe data reuse